Toxicological_concerns - Summary.md 2.3 KB

Covax Toxicology

Stephanie Seneff

Summary

  • Synthetic cationic lipids easily taken up (LDL-like), resistant to enzyme degradation, appearing as human molecule

Nucleoside / Protein

  • Pseudouridine / 2 prolines added to middle of sequence
  • Locked spike disables ACE-2 receptors
  • Codon-optimized to maximize protein production
  • Spike/mRNA in lymph 60+ days, and in bone marrow

Disease Concern

  • Suppess BRCA protein (breast cancer)
  • VAERS signals: rate ~1 order magnitude higher. 97-99% of reports for thrombosis/heart/neurodegen
  • Exosomes: particles placed in exosomes at spleen and distributed along vagus nerve
  • Type-1 interferon response disruption
  • Disruption of CD4+ monocytes

Michael Palmer

  • Cleaved spike inducing biological activities
  • Destroy cells that produced antigen
  • Cationic lipid breaks down membrane barriers, including of mitochondria
  • Progressive destruction of cells with each subsequent vaccination
    • classic vaccines include antigen, and are thus marked for destruction and to be discarded upon re-vaccination
    • this does not occur with mRNA vaccines, thus the antigen is always expressed by cells and those cells always induce a response from the immune system

Spike

  • Attack cells that express spike
  • Particularly capillaries/venules
  • Spike expressed by endothelial cells causes damage allowing blood to access tissue beyond endothelium where blood clotting will occur
  • Spike protein found in exosomes of patients and study subjects 4 months after vaccination
    • Vaccine every 6 months could mean continuous production of spike protein / continuous reactivity of immune system

Heart

  • Easiest to detect heart issues with young people
  • Many heart disease-related deaths might be due to vaccine

Immunosuppression

  • Reactivation of viruses (shingles/varicella zoster)
  • Cancer / reactivation of cancer
  • Ulcers in mouth
  • Endocrine-limited bandwidth of inflammation prevents upregulation of immune activity in order to effectively combat pathogens

Pharmacokinetics

  • In blood 15 mins post-IM administration
  • Peak @ 2 hrs
  • Accumulate in liver, spleen, ovaries, adrenals
  • Should expect accumulation in placenta and breast glands

DNA Damage

  • Cationic lipids are known to damage mitochondria, leading to ROS and DNA damage -